Japan Asset Strategy Leader, Immunology

Job description

About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube. Purpose Statement: Japan Asset Strategy Leader (JASL) serves as the matrix team leader to bring impactful medicine to patients as quickly and efficiently as possible, working as one with global team and internal/external stakeholders by driving plan & implementation of the most competitive Japan asset strategies for asset value maximization Responsibilities: Lead development and execution of Japan asset strategy for individual asset programs which contribute to sustainable, successful growth of AbbVie Ensure that the individual development plan maximize asset value to AbbVie (not limited to Japan, but also added value globally when applicable) through effective, rapid and broad development of pipeline assets, with adequate consideration of market access, medical, Loss of Exclusivity (LOE) and commercialization aspects Be accountable for assigned assets in Japan through asset life cycle to key stakeholders/management Maximize performance of Japan Asset Strategy Team (JAST) with leading and driving planning & execution of Japan asset strategy Foster innovation/enterprise mindset in JAST Roles: Develop and drive an integrated Japan asset strategy for value maximization Create the most competitive asset strategy based on medical needs, regulatory requirements, commercial needs, market access/pricing, and LOE maximization Bring new products to the market through fastest and efficient approach with required quality Provide inputs to Asset Strategy Team (AST) ensuring Japan asset strategy is integrated into the global asset strategy as the primary contact person Ensure alignment on the program strategies within JAST and with relevant stakeholders including AST and review bodies in Japan (e.g., Japan R&D Huddles, TA Review Meeting, Japan NPI, Intercon Pipeline Review etc.) Represent JAST to the relevant stakeholders Lead JAST Set challenging individual asset-related shared goals together with the team members Maintain motivation within the team: Foster ‘trust, transparency, and phycological safety’ within the team to optimize team performance For asset-related activities, provide regular feedback to team members concerning their contribution to team performance to shared goals Maintain a function-neutral position in prioritizing actions and making decisions, with an eye toward optimizing asset value in a timely and high-quality fashion Is accountable for advancing assets on time, with being mindful of allocated resources and required quality Background/Experience At least 5 years in drug development and experience of one or more NDAs, or equivalent knowledge Experience leading a team in a cross-functional environment Education Graduate from Medical School, College of Nursing, College of Pharmacy, College of Science/Agriculture, or life-science course (Holder of master degree or PhD degree is preferable), or equivalent education Knowledge Expertise in a relevant discipline associated with drug development and/or commercialization Sufficient knowledge in the therapeutic area assigned General knowledge of pharmaceutical associations (Seiyakukyo and Pharma etc.). The latest guidelines and regulations (GCP etc.) TOEIC score is 850 or higher, or equivalent skill for English communication. Skill Strategic Thinking Leadership/Decision-making Problem-solving Coaching Communication skill/Storytelling with both of Japanese and English アッヴィは、機会均等を重視する雇用主であり、誠実な企業活動、革新の推進、人々の生活への貢献、そして地域社会への貢献に努めています。雇用機会均等に向けて、障がいを持つ方々も積極的に支援しています。